ArticleFrontiers in immunology2025
Prognostic significance of systemic immunoinflammatory biomarkers in patients with clear cell renal cell carcinoma: a retrospective multicenter analysis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prognostic significance of systemic immunoinflammatory biomarkers and pathological features in clear cell renal cell carcinoma: a multicenter study.Annals of medicine · 2026Trial
- Prognostic value of systemic immune-inflammation index in patients with localized and advanced renal cell carcinoma: a systematic review and meta-analysis.Translational andrology and urology · 2026Article
- Association between systemic inflammatory response index and the prognosis of patients with localized and advanced renal cell carcinoma: a systematic review and meta-analysis.Translational andrology and urology · 2026Article
- Prognostic value of preoperative inflammatory cell-to-HDL cholesterol ratios in patients with non-metastatic clear cell renal cell carcinoma.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This study aims to investigate the associations between blood laboratory findings, systemic immune-inflammatory factors, ISUP grade, and prognostic outcomes in patients diagnosed with clear cell renal cell carcinoma (ccRCC). Methods: Data were collected from patients diagnosed with ccRCC at the First People's Hospital of Yunnan Province and Xiangya Hospital of Central South University between 2010 and 2022, encompassing pertinent pathological and clinical information. We employed ordered logistic regression analysis to establish the ISUP grading model and conducted association analyses to explore the relationship between ISUP classification and the 2-year survival rate. Results: A total of 1,635 patients were included in the study. Our findings indicate that ISUP grading is significantly correlated with serum albumin levels, blood chloride concentrations, the platelet-to-lymphocyte ratio (PLR), and the systemic inflammation response index (SIRI). The preoperative 2-year survival model demonstrated associations with platelet counts (PLT), albumin levels, blood chloride concentrations, and PLR, AUC (0.776 95%IC 0.710, 0.843). Furthermore, the postoperative 2-year survival model exhibited robust correlations with PLT, albumin levels, blood chloride concentrations, PLR, and ISUP grade, AUC (0.877, 95%IC 0.825, 0.917). Conclusion: This study demonstrated the relationship between systemic immune markers, ISUP classification, and prognosis. It established preoperative models for predicting ISUP classification, as well as models for predicting 2-year survival rates both preoperatively and postoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.